"I see we're back to talking about offices and how the FDA deems...

"I see we're back to talking about offices and how the FDA deems them crucial to trial approval. Good to know how your brain works (pic below for the MSB folks who can't read and need pictures to understand)."

Again, it is Cynata that has been involved in TWO articles THIS YEAR informing readers of the DETAILS of FDA TRIAL APPROVALS. It's not a demonstration of how my brain works, as I wasn't involved in the articles?




The OA trial is with the TGA. And Cynata yesterday stated that another trial will probably be required. Not might!

Now we know of another TGA P3 trial that Cynata was involved in until recently, don't we? Are you starting to get it?

The common denominator on both P3 trials is the TGA. One stopped suddenly a few short WEEKS after another hospital was added and the other will PROBABLY need another P3.

And TWO articles wrt to FDA approvals by Cynata that has never done a FDA trial ever?

Can you see a not-so subtle connection here?

Why is another MSC ASX listed company dual listed on the NASDAQ? That was done YEARS ago.

And Ross has stated that the first to commercialise for Cynata will most likely be GVHD? Which is touted to be with the FDA but we know the P2 FDA trial has yet to start candidate enrolment and is 'months' away from doing so.

Here's a pic for you:



The colour blue suits Ross.